• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA:心房颤动的新兴生物标志物。

MicroRNAs: Emerging biomarkers for atrial fibrillation.

机构信息

Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.

Cardiology Department of First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

J Cardiol. 2019 Dec;74(6):475-482. doi: 10.1016/j.jjcc.2019.05.018. Epub 2019 Jul 16.

DOI:10.1016/j.jjcc.2019.05.018
PMID:31324570
Abstract

Atrial fibrillation (AF) causes severe cardiac dysrhythmia among patients with cardiovascular diseases. AF increases the risk of stroke and heart failure and is a growing public health concern. AF is also associated with various disease conditions such as hypertension, coronary artery disease, aging, and diabetes mellitus. The mechanism underlying AF is not completely understood due to its complexity. However, experimental and clinical data have revealed that the prevalence of this disease is associated with atrial arrhythmogenic remodeling. Currently, there are no biomarkers that are available for the early diagnosis of AF. Several studies have proposed microRNAs (miRNAs) as useful biomarkers for the diagnosis of AF due to their stability and easy availability both in atrial tissue and circulating blood. miRNAs play an important role in the development of the heart. The dysregulation of miRNA expression is associated with cardiac remodeling. Genetic factors strongly contribute to the pathogenesis of AF. Recently, single nucleotide polymorphisms (SNPs) in various genes and miRNAs have been reported to be associated with AF. The aim of this review was to discuss the correlation between SNPs in miRNAs and AF, including those miRNAs that are commonly reported as potential biomarkers for AF.

摘要

心房颤动(AF)会导致心血管疾病患者出现严重的心律失常。AF 会增加中风和心力衰竭的风险,是一个日益受到关注的公共卫生问题。AF 还与各种疾病状况有关,如高血压、冠状动脉疾病、衰老和糖尿病。由于其复杂性,AF 的发病机制尚不完全清楚。然而,实验和临床数据表明,这种疾病的流行与心房心律失常性重构有关。目前,尚无可用于 AF 早期诊断的生物标志物。由于其在心房组织和循环血液中的稳定性和易于获得性,一些研究已经提出 microRNAs(miRNAs)作为有用的 AF 诊断生物标志物。miRNAs 在心脏发育中起着重要作用。miRNA 表达的失调与心脏重构有关。遗传因素对 AF 的发病机制有很大的影响。最近,已经报道了各种基因和 miRNAs 中的单核苷酸多态性(SNPs)与 AF 相关。本综述的目的是讨论 miRNAs 中的 SNPs 与 AF 之间的相关性,包括那些通常被报道为 AF 潜在生物标志物的 miRNAs。

相似文献

1
MicroRNAs: Emerging biomarkers for atrial fibrillation.微小 RNA:心房颤动的新兴生物标志物。
J Cardiol. 2019 Dec;74(6):475-482. doi: 10.1016/j.jjcc.2019.05.018. Epub 2019 Jul 16.
2
Atrial remodeling in atrial fibrillation and association between microRNA network and atrial fibrillation.心房颤动中的心房重构及 microRNA 网络与心房颤动的关系。
Sci China Life Sci. 2011 Dec;54(12):1097-102. doi: 10.1007/s11427-011-4241-3. Epub 2012 Jan 7.
3
Relations between plasma microRNAs, echocardiographic markers of atrial remodeling, and atrial fibrillation: Data from the Framingham Offspring study.血浆 microRNAs 与心房重构的超声心动图标志物及心房颤动的关系:弗雷明汉后代研究的数据。
PLoS One. 2020 Aug 19;15(8):e0236960. doi: 10.1371/journal.pone.0236960. eCollection 2020.
4
Circulating MicroRNAs as Potential Biomarkers of Atrial Fibrillation.循环微小RNA作为心房颤动的潜在生物标志物
Biomed Res Int. 2017;2017:7804763. doi: 10.1155/2017/7804763. Epub 2017 Mar 2.
5
Combined Analysis of Human and Experimental Murine Samples Identified Novel Circulating MicroRNAs as Biomarkers for Atrial Fibrillation.联合分析人类和实验性小鼠样本鉴定新型循环 microRNAs 作为心房颤动的生物标志物。
Circ J. 2018 Mar 23;82(4):965-973. doi: 10.1253/circj.CJ-17-1194. Epub 2018 Feb 5.
6
Molecular mechanism of atrial remodeling in patients with aging atrial fibrillation under the expression of microRNA-1 and microRNA-21.衰老性心房颤动患者中 microRNA-1 和 microRNA-21 表达的心房重构分子机制。
Bioengineered. 2021 Dec;12(2):12905-12916. doi: 10.1080/21655979.2021.2008668.
7
Plasma microRNAs are associated with atrial fibrillation and change after catheter ablation (the miRhythm study).血浆微小RNA与心房颤动相关,并在导管消融术后发生变化(miRhythm研究)。
Heart Rhythm. 2015 Jan;12(1):3-10. doi: 10.1016/j.hrthm.2014.09.050. Epub 2014 Oct 9.
8
Atrial Fibrillation in Heart Failure Is Associated with High Levels of Circulating microRNA-199a-5p and 22-5p and a Defective Regulation of Intracellular Calcium and Cell-to-Cell Communication.心力衰竭中的心房颤动与循环中高水平的微小RNA-199a-5p和22-5p以及细胞内钙调节缺陷和细胞间通讯有关。
Int J Mol Sci. 2021 Sep 26;22(19):10377. doi: 10.3390/ijms221910377.
9
MicroRNAs as Biomarkers for Acute Atrial Remodeling in Marathon Runners (The miRathon Study--A Sub-Study of the Munich Marathon Study).微小RNA作为马拉松运动员急性心房重塑的生物标志物(miRathon研究——慕尼黑马拉松研究的子研究)
PLoS One. 2016 Feb 9;11(2):e0148599. doi: 10.1371/journal.pone.0148599. eCollection 2016.
10
MicroRNAs in Atrial Fibrillation.微 RNA 与心房颤动
Curr Med Chem. 2019;26(5):855-863. doi: 10.2174/0929867324666170920151024.

引用本文的文献

1
Circulating miRNA-486 as a novel diagnostic biomarker for right ventricular remodeling.循环miRNA-486作为右心室重塑的新型诊断生物标志物。
Front Cardiovasc Med. 2025 Jan 29;12:1518022. doi: 10.3389/fcvm.2025.1518022. eCollection 2025.
2
MicroRNAs as Prognostic Biomarkers for Atrial Fibrillation Recurrence After Catheter Ablation: Current Evidence and Future Directions.微小RNA作为导管消融术后房颤复发的预后生物标志物:当前证据与未来方向
Biomedicines. 2024 Dec 26;13(1):32. doi: 10.3390/biomedicines13010032.
3
Epigenetic Regulation in Myocardial Fibroblasts and Its Impact on Cardiovascular Diseases.
心肌成纤维细胞中的表观遗传调控及其对心血管疾病的影响。
Pharmaceuticals (Basel). 2024 Oct 10;17(10):1353. doi: 10.3390/ph17101353.
4
Pathophysiological Mechanisms of Psychosis-Induced Atrial Fibrillation: The Links between Mental Disorder and Arrhythmia.精神病性心房颤动的病理生理机制:精神障碍与心律失常之间的联系
Rev Cardiovasc Med. 2024 Sep 24;25(9):343. doi: 10.31083/j.rcm2509343. eCollection 2024 Sep.
5
Bruton tyrosine kinase inhibitor-related atrial fibrillation and its implications in the treatment of B-cell lymphoma.布鲁顿酪氨酸激酶抑制剂相关的心房颤动及其在B细胞淋巴瘤治疗中的意义
Front Cardiovasc Med. 2024 Jul 26;11:1408983. doi: 10.3389/fcvm.2024.1408983. eCollection 2024.
6
miR-338-5p regulated the NF-κB/MAPK pathway to alleviate inflammation and oxidative stress by targeting IL-6 in rats with atrial fibrillation.在房颤大鼠中,miR-338-5p通过靶向白细胞介素-6调控核因子κB/丝裂原活化蛋白激酶信号通路,以减轻炎症和氧化应激。
3 Biotech. 2024 Jul;14(7):182. doi: 10.1007/s13205-024-04024-4. Epub 2024 Jun 28.
7
Deciphering the Role of microRNAs: Unveiling Clinical Biomarkers and Therapeutic Avenues in Atrial Fibrillation and Associated Stroke-A Systematic Review.解析 microRNAs 的作用:揭示心房颤动及相关卒中的临床生物标志物和治疗新途径——系统综述。
Int J Mol Sci. 2024 May 20;25(10):5568. doi: 10.3390/ijms25105568.
8
Principles and Limitations of miRNA Purification and Analysis in Whole Blood Collected during Ablation Procedure from Patients with Atrial Fibrillation.房颤患者消融术中采集的全血中miRNA纯化与分析的原理及局限性
J Clin Med. 2024 Mar 25;13(7):1898. doi: 10.3390/jcm13071898.
9
Pathophysiology and clinical relevance of atrial myopathy.心房肌病的病理生理学和临床相关性。
Basic Res Cardiol. 2024 Apr;119(2):215-242. doi: 10.1007/s00395-024-01038-0. Epub 2024 Mar 12.
10
Plasma miR-486-5p Expression Is Upregulated in Atrial Fibrillation Patients with Broader Low-Voltage Areas.血浆 miR-486-5p 表达在伴有更广泛低电压区的心房颤动患者中上调。
Int J Mol Sci. 2023 Oct 17;24(20):15248. doi: 10.3390/ijms242015248.